CME GROUP, INC Clarius Group LLC holding in Form 13-F
Clarius Group LLC reported holding of CME
This chart displays the historical ownership data of CME by Clarius Group LLC. At the end of Q2 2016 the holding was valued at $959,000. This decreased to $439,320 at the end of Q1 2025.
| Date | Holding Value |
|---|---|
| 959000 | |
| 1029000 | |
| 1157000 | |
| 1157000 | |
| 0 | |
| 205000 | |
| 306000 | |
| 464000 | |
| 467000 | |
| 457000 | |
| 415000 | |
| 368000 | |
| 331000 | |
| 471000 | |
| 435000 | |
| 391000 | |
| 498000 | |
| 498000 | |
| 495000 | |
| 463000 | |
| 1634000 | |
| 523233 | |
| 457110 | |
| 456702 | |
| 449420 | |
| 367715 | |
| 331468 | |
| 355908 | |
| 377606 | |
| 439320 |
About CME GROUP INC
CME Group provides a global marketplace for trading futures, options, cash, and over-the-counter (OTC) products. The company offers a variety of products in sectors such as interest rates, equity indexes, foreign exchange, and commodities. CME Group operates primarily through its electronic trading platform, CME Globex, and provides clearing and settlement services via CME Clearing. The company also runs cash markets through BrokerTec and EBS, focusing on fixed income and foreign exchange products.
CME Group operates in the derivatives trading, clearing, and cash markets industries. The company generates revenue mainly from clearing and transaction fees, with a significant portion of its income coming from these services. Additionally, CME Group earns from market data services, offering real-time and historical data to its clients. The company's primary customers include institutional investors, corporations, and financial institutions, with a notable international client base.
The operational structure of CME Group includes various divisions and subsidiaries acquired over time, such as CBOT Holdings, NYMEX, and NEX Group, which have expanded its product offerings and client reach. Key factors impacting CME Group's business performance include trading volumes, product diversity, technological capabilities, and competition from other exchanges and trading platforms. The company must continuously innovate and enhance its offerings to maintain its position in the market.
Disclaimer
FilingExplorer.com is not affiliated with, endorsed by, or in any way officially connected with any of the securities, funds, or companies mentioned on this site. The information provided is sourced from publicly available datasets and is presented for informational purposes only. While we strive for accuracy, we do not guarantee the completeness, timeliness, or accuracy of any information on this site. Users should not rely solely on this information for making investment decisions and should always conduct their own research or consult with a qualified financial advisor. Security and company summaries are based on public data available in recent SEC filings, and may not be entirely accurate. The mention of any security does not constitute a recommendation to buy, sell, or hold that or any other security. FilingExplorer.com is not responsible for any investment decisions made based on the information provided on this site.
See our Terms of Service
Clarius Group LLC reported holdings of CME from Q2 2016 to Q1 2025
| Reporting period | Holding Type | Market Value | % of portfolio | Shares | Change in shares | % Change in shares |
|---|---|---|---|---|---|---|
| Q2 2016 | Stock | $959,000 | 0.51% | 9,851 | 9,851 | 0 |
| Q3 2016 | Stock | $1,029,000 | 0.48% | 9,851 | 0 | 0 |
| Q4 2016 | Stock | $1,157,000 | 0.49% | 10,026 | 175 | 1.78% |
| Q4 2016 | Stock | $1,157,000 | 0.49% | 10,026 | 175 | 1.78% |
| Q1 2017 | Stock | $0 | 0 | 0 | -10,026 | -100.0% |
| Q1 2019 | Stock | $205,000 | 0.05% | 1,246 | 1,246 | 0 |
| Q2 2019 | Stock | $306,000 | 0.06% | 1,578 | 332 | 26.65% |
| Q3 2019 | Stock | $464,000 | 0.09% | 2,196 | 618 | 39.16% |
| Q4 2019 | Stock | $467,000 | 0.07% | 2,277 | 81 | 3.69% |
| Q1 2020 | Stock | $457,000 | 0.09% | 2,643 | 366 | 16.07% |
| Q2 2020 | Stock | $415,000 | 0.06% | 2,556 | -87 | -3.29% |
| Q3 2020 | Stock | $368,000 | 0.05% | 2,202 | -354 | -13.85% |
| Q4 2020 | Stock | $331,000 | 0.04% | 1,820 | -382 | -17.35% |
| Q1 2021 | Stock | $471,000 | 0.05% | 2,305 | 485 | 26.65% |
| Q2 2021 | Stock | $435,000 | 0.04% | 2,044 | -261 | -11.32% |
| Q3 2021 | Stock | $391,000 | 0.04% | 2,024 | -20 | -0.98% |
| Q4 2021 | Stock | $498,000 | 0.04% | 2,180 | 156 | 7.71% |
| Q1 2022 | Stock | $498,000 | 0.04% | 2,180 | 0 | 0 |
| Q2 2022 | Stock | $495,000 | 0.05% | 2,416 | 236 | 10.83% |
| Q3 2022 | Stock | $463,000 | 0.05% | 2,615 | 199 | 8.24% |
| Q4 2022 | Stock | $1,634,000 | 0.15% | 9,719 | 7,104 | 271.66% |
| Q1 2023 | Stock | $523,233 | 0.04% | 2,732 | -6,987 | -71.89% |
| Q2 2023 | Stock | $457,110 | 0.04% | 2,467 | -265 | -9.7% |
| Q3 2023 | Stock | $456,702 | 0.04% | 2,281 | -186 | -7.54% |
| Q4 2023 | Stock | $449,420 | 0.04% | 2,134 | -147 | -6.44% |
| Q1 2024 | Stock | $367,715 | 0.03% | 1,708 | -426 | -19.96% |
| Q2 2024 | Stock | $331,468 | 0.02% | 1,686 | -22 | -1.29% |
| Q3 2024 | Stock | $355,908 | 0.02% | 1,633 | -53 | -3.14% |
| Q4 2024 | Stock | $377,606 | 0.03% | 1,626 | -7 | -0.43% |
| Q1 2025 | Stock | $439,320 | 0.03% | 1,656 | 30 | 1.85% |